Johnson & Johnson Innovation - JJDC, Inc.
CIK
924020
Location
NEW BRUNSWICK, NJ
Portfolio Value
Small
$916,728,650
Diversification
Moderately concentrated
Reports for
JOHNSON & JOHNSON
Filing Date
Global Rank
#1,608
/ 6,045
▲ 188
· as of Jun 2021
Top Industry
Biotechnology
89.1%
Period ended 5 years ago
Filed Aug 3, 2021 · 5y
6 quarters · since Mar 2020
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
17 tracked positions · as of Jun 30, 2021 · Δ vs Mar 31, 2021Top Position
32.0%
−7.3 pts
Top 5
91.4%
−0.5 pts
Top 10
99.9%
−0.1 pts
HHI
2,232
Moderately concentrated−443
Portfolio Trend
6 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2021| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $916,728,650 |
| Technology | 0.0% | $0 |
| Unclassified | 0.0% | $0 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SENS | Senseonics Holdings, Inc. | −437,648 | 54,621 | $209,744 | |
| No positions match the current search. | |||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
17 tracked positions ·
$916,728,650 total
· filing declares
21 positions · $978,187,000
· as of Jun 30, 2021
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| FATE |
Fate Therapeutics Inc
Healthcare
|
Held | 3,379,064 | $293,268,964 | 31.99% | |
| ARWR |
Arrowhead Pharmaceuticals, Inc.
Healthcare
|
Held | 3,260,869 | $270,065,170 | 29.46% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Held | 2,449,183 | $109,919,333 | 11.99% | |
| CVRX |
CVRx, Inc.
Healthcare
|
NEW | 3,495,575 | $97,876,100 | 10.68% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Held | 1,629,173 | $66,877,551 | 7.30% | |
| MGTX |
MeiraGTx Holdings plc
Healthcare
|
Held | 2,898,550 | $44,927,525 | 4.90% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Held | 1,074,658 | $20,042,371 | 2.19% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 728,944 | $7,500,833 | 0.82% | |
| ALDX |
Aldeyra Therapeutics, Inc.
Healthcare
|
Held | 394,834 | $4,473,469 | 0.49% | |
| NPCE |
NeuroPace Inc
Healthcare
|
NEW | 55,435 | $1,318,798 | 0.14% | |
| LUNG |
Pulmonx Corp
Healthcare
|
Held | 5,639 | $248,792 | 0.03% | |
| SENS |
Senseonics Holdings, Inc.
Healthcare
|
Reduced | 54,621 | $209,744 | 0.02% | |
|
|
Held | 811,295 | $0 | 0.00% | ||
|
|
Held | 1,607,044 | $0 | 0.00% | ||
|
|
NEW | 16,553 | $0 | 0.00% | ||
|
|
Held | 3,670,516 | $0 | 0.00% | ||
| HLSQ |
Tessera Defense & Homeland Security Inc.
Technology
|
Held | 2,133,402 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.